{"title":"保留肌肉背阔肌皮瓣在肉瘤缺损重建中的功能和供区发病率结局:一项单中心队列研究","authors":"Bassel Hoteit , Anais Delgove , Diane Adam , Magali Fau , Raphael Blaquiere , Audrey Michot","doi":"10.1016/j.ejso.2025.109994","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>The latissimus dorsi musculocutaneous flap (LD) is widely used in trunk and limb reconstruction after soft tissue sarcoma excision. The muscle-sparing technique (MSLD) appears to reduce donor site morbidity. The main objective of this study was to assess functional morbidity after reconstruction with LD and MSLD using the QuickDash score. Secondary objectives aimed to evaluate postoperative complications and hospital length of stay.</div></div><div><h3>Patients and method</h3><div>This was a prospective single-center study including adult patients undergoing reconstruction with LD or MSLD flaps after resection of a soft tissue sarcoma, who completed a QuickDash questionnaire preoperatively and postoperatively between 2018 and 2024.</div></div><div><h3>Results</h3><div>30 patients were included in the study: 17 in the MSLD group and 13 in the LD group. There was no significant difference between the ΔQuickDash in the MSLD group (13.1) and the LD group (9.7) (p = 0.729). The MSLD group had a shorter average hospitalization length (5.9 days) compared to the LD group (9.3 days) (p < 0.05). The seroma rate was higher in the LD group (46.2 %) than in the MSLD group (17.6 %) without statistically significant difference (p = 0.2).</div></div><div><h3>Conclusion</h3><div>This study does not show a reduction in functional morbidity of the donor site in MSLD compared to LD in oncoplastic surgery of sarcoma. MSLD presents the advantage of a shorter hospitalization duration, probably related to a lower complication rate. MSLD and LD seem to have different indications.</div></div>","PeriodicalId":11522,"journal":{"name":"Ejso","volume":"51 7","pages":"Article 109994"},"PeriodicalIF":3.5000,"publicationDate":"2025-03-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Functional and donor-site morbidity outcomes of muscle-sparing latissimus dorsi flap in sarcoma defects reconstruction: A single-center cohort study\",\"authors\":\"Bassel Hoteit , Anais Delgove , Diane Adam , Magali Fau , Raphael Blaquiere , Audrey Michot\",\"doi\":\"10.1016/j.ejso.2025.109994\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Introduction</h3><div>The latissimus dorsi musculocutaneous flap (LD) is widely used in trunk and limb reconstruction after soft tissue sarcoma excision. The muscle-sparing technique (MSLD) appears to reduce donor site morbidity. The main objective of this study was to assess functional morbidity after reconstruction with LD and MSLD using the QuickDash score. Secondary objectives aimed to evaluate postoperative complications and hospital length of stay.</div></div><div><h3>Patients and method</h3><div>This was a prospective single-center study including adult patients undergoing reconstruction with LD or MSLD flaps after resection of a soft tissue sarcoma, who completed a QuickDash questionnaire preoperatively and postoperatively between 2018 and 2024.</div></div><div><h3>Results</h3><div>30 patients were included in the study: 17 in the MSLD group and 13 in the LD group. There was no significant difference between the ΔQuickDash in the MSLD group (13.1) and the LD group (9.7) (p = 0.729). The MSLD group had a shorter average hospitalization length (5.9 days) compared to the LD group (9.3 days) (p < 0.05). The seroma rate was higher in the LD group (46.2 %) than in the MSLD group (17.6 %) without statistically significant difference (p = 0.2).</div></div><div><h3>Conclusion</h3><div>This study does not show a reduction in functional morbidity of the donor site in MSLD compared to LD in oncoplastic surgery of sarcoma. MSLD presents the advantage of a shorter hospitalization duration, probably related to a lower complication rate. MSLD and LD seem to have different indications.</div></div>\",\"PeriodicalId\":11522,\"journal\":{\"name\":\"Ejso\",\"volume\":\"51 7\",\"pages\":\"Article 109994\"},\"PeriodicalIF\":3.5000,\"publicationDate\":\"2025-03-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Ejso\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0748798325004226\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ejso","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0748798325004226","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
Functional and donor-site morbidity outcomes of muscle-sparing latissimus dorsi flap in sarcoma defects reconstruction: A single-center cohort study
Introduction
The latissimus dorsi musculocutaneous flap (LD) is widely used in trunk and limb reconstruction after soft tissue sarcoma excision. The muscle-sparing technique (MSLD) appears to reduce donor site morbidity. The main objective of this study was to assess functional morbidity after reconstruction with LD and MSLD using the QuickDash score. Secondary objectives aimed to evaluate postoperative complications and hospital length of stay.
Patients and method
This was a prospective single-center study including adult patients undergoing reconstruction with LD or MSLD flaps after resection of a soft tissue sarcoma, who completed a QuickDash questionnaire preoperatively and postoperatively between 2018 and 2024.
Results
30 patients were included in the study: 17 in the MSLD group and 13 in the LD group. There was no significant difference between the ΔQuickDash in the MSLD group (13.1) and the LD group (9.7) (p = 0.729). The MSLD group had a shorter average hospitalization length (5.9 days) compared to the LD group (9.3 days) (p < 0.05). The seroma rate was higher in the LD group (46.2 %) than in the MSLD group (17.6 %) without statistically significant difference (p = 0.2).
Conclusion
This study does not show a reduction in functional morbidity of the donor site in MSLD compared to LD in oncoplastic surgery of sarcoma. MSLD presents the advantage of a shorter hospitalization duration, probably related to a lower complication rate. MSLD and LD seem to have different indications.
期刊介绍:
JSO - European Journal of Surgical Oncology ("the Journal of Cancer Surgery") is the Official Journal of the European Society of Surgical Oncology and BASO ~ the Association for Cancer Surgery.
The EJSO aims to advance surgical oncology research and practice through the publication of original research articles, review articles, editorials, debates and correspondence.